{
  "trial_id": "NCT03913780",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "surgery that go to a phase II cardiac rehabilitation program, which at the time had to sign an informed consent endorsed by the ethics and research committee of the institution.",
      "label": "met"
    },
    {
      "criterion": "Likewise, it was necessary for participants to have heart failure with ejection fraction greater than 35%",
      "label": "met"
    },
    {
      "criterion": "Participants do not have any inconvenience when doing the questionnaires, tests and measures that the investigation demands",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "rate >120 bpm (beats per minute) at rest, systolic blood pressure >190 mmHg, diastolic blood pressure >120 mmHg were discarded.",
      "label": "triggers"
    },
    {
      "criterion": "The participant had the option of being able to withdraw from the research when he wished or to show hemodynamic instability without improving during any test or during the intervention process.",
      "label": "unknown"
    }
  ],
  "notes": "Patient has a history of Burkitt's lymphoma and primary cardiac lymphoma, which may be a contraindication for cardiac rehabilitation. However, they do not have any other exclusion criteria mentioned.",
  "_meta": {
    "topic_id": "4",
    "trial_id": "NCT03913780",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}